Cure Blindness Project Press Release
FOR IMMEDIATE RELEASE

Eye Care Expansion Project Positions Nepal as Global Eye Care Innovator “God of Sight” Dr. Sanduk Ruit Kicks Off Multi-City US Speaking Tour

Media Contacts

Lelin Kandel  
[email protected]
858-371-1593  

Phillip Sontag
[email protected]
917-446-4123
 

(Kathmandu, Nepal) May 2025 - Nearly three decades ago, when Dr. Sanduk Ruit and his team proposed the idea of producing high-quality intraocular lenses (IOLs) in Nepal, they were met with skepticism and criticism. The vision was dismissed as overly ambitious, an idea too bold for a developing country. Undeterred, Dr. Ruit and his team pursued their mission to establish a facility that could produce IOLs on par with leading global manufacturers. Today, the lenses manufactured at Tilganga’s IOL Laboratory have been implanted in over 6.5 million eyes across the globe — a powerful testament to what determination and innovation can achieve.

Dr. Ruit is embarking on a multi-city tour across the US addressing audiences about this humanitarian initiative and future plans to expand the facility. Expansion will allow the production of more high-quality IOLs for the treatment of those with avoidable blindness.  

 

Dr. Sanduk Ruit US Speaking Tour Dates (Public Invited) 

Unless noted, all events are free to attend.

May 17 (2-5pm): Washington DC  
Fairfax Church of Christ  
3901 Rugby Road, Fairfax  
https://tinyurl.com/DrRuitInVirginia

May 18 (5:30-8pm): West Palm Beach/Miami 
Wellington Community Center
12150 Forest Hill Blvd, Wellington
https://floridanepalese.org/fundraising-dinner-with-dr-sanduk-ruit/

May 22 (7-8:30pm): Boston  
594 Washington Street, Braintree
https:/tinyurl.com/DrRuitinBoston

May 23 (6-8pm): NYC Community College Group  
Mainstage Theater of LaGuardia Performance Arts Center 
31-10 Thomson Ave, Long Island City
https://tinyurl.com/DrRuitInNewYork 

May 25 (6-9pm): Baltimore 
$100 dinner ticket pp  
1700 Van Bibber Rd, Edgewood, MD 
https://tinyurl.com/DrRuitInMaryland 

May 31 (5-8pm): Dallas
The University of Texas at Arlington  
Rosebud Theater, 300 W. 1st Street, Arlington
https://tinyurl.com/drruit  

June 1 (3:30-6:30pm): Raleigh, NC 
309 Aviation Pkwy, Morrisville, NC  
https://tinyurl.com/drruitinraleigh

June 2 (6-8pm): Charlotte, NC
UNCC Charlotte  
9119 University Rd, Charlotte, NC  
https://tinyurl.com/DrRuitInCharlotte  
 

The Impact of Tilganga’s IOL Laboratory

Since its establishment in 1994, Tilganga’s IOL lab has accomplished extraordinary milestones:

Expanding for the Future: The Hetauda Project

To build on this legacy, Tilganga is planning a major expansion to Hetauda. This new facility will increase production capacity and introduce premium lens types to serve a broader international market while maintaining the focus on affordability for low-income populations.

Operating as a profit not distributing industry, the expanded lab will reinvest earnings to sustain and enhance its humanitarian mission. Key goals of the planned Hetauda IOL facility include:

While Tilganga has been able to source the land required to build the facility, the project requires an estimated investment of approximately USD 5.2 million to build and operationalise the facility.

Today, more than 6.5 million individuals have been cured of blindness owing to Tilganga’s IOL lab. The planned expansion in Hetauda is an opportunity to amplify this impact, ensuring that no one remains blind because of the high cost of care, while elevating Nepal as a global leader in eye innovation. The success of this plant will position Nepal on the international stage for the manufacturing of high-precision devices with reproducible results. 

###

About Cure Blindness Project

Founded as Himalayan Cataract Project, Cure Blindness Project today celebrates 30 years of restoring sight. This singular mission expanded from its origins in Nepal to 30 countries with high-quality eye care, education, and world-class eye care infrastructure. Together with partners, Cure Blindness Project has provided over 1.6 million sight-restoring surgeries and provided screening and basic care to over 16.5 million people.

Download PDF